These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 83331)

  • 1. Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor).
    Epstein WL; Byers VS
    J Allergy Clin Immunol; 1979 Feb; 63(2):111-5. PubMed ID: 83331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berylliosis as an auto-immune disorder.
    Reeves AL
    Ann Clin Lab Sci; 1976; 6(3):256-62. PubMed ID: 942183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational and non-occupational allergic contact dermatitis from beryllium.
    Vilaplana J; Romaguera C; Grimalt F
    Contact Dermatitis; 1992 May; 26(5):295-8. PubMed ID: 1395589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beryllium granuloma].
    Grupper C; Hincky M; Edelson Y
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(2):156-7. PubMed ID: 4318249
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed hypersensitivity study on zirconium compounds and beryllium sulfate.
    Kang KY; Bice D; Salvaggio J
    Med J Osaka Univ; 1976 Mar; 26(3-4):131-45. PubMed ID: 979859
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
    Wilson GB; Fudenberg HH; Horsmanheimo M
    J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appearance of T-cell subpopulations during the time course of beryllium-induced granulomas.
    Maceira JM; Fukuyama K; Epstein WL
    J Invest Dermatol; 1984 Nov; 83(5):314-6. PubMed ID: 6238101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity in gnotobiotic primates induced by transfer factor.
    Eichberg JW; Steele RW; Kalter SS; Kniker WT; Heberling RL; Eller JJ; Rodriguez AR
    Cell Immunol; 1976 Sep; 26(1):114-9. PubMed ID: 61071
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous patch test sensitization to 4 chemically unrelated compounds in a standard test series.
    Bruze M
    Contact Dermatitis; 1984 Jul; 11(1):48-9. PubMed ID: 6744844
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergological research concerning cadmium, beryllium, arsenic and diazodiethylaniline].
    Scarpa C; Ferrea E
    Minerva Dermatol; 1967 Apr; 42(4):126-9. PubMed ID: 4235468
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact dermatitis to chlorprothixene.
    Lepp U; Schlaak M; Schulz KH
    Allergy; 1998 Jul; 53(7):718-9. PubMed ID: 9700045
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantization of nickel and beryllium leakage from base metal casting alloys.
    Covington JS; McBride MA; Slagle WF; Disney AL
    J Prosthet Dent; 1985 Jul; 54(1):127-36. PubMed ID: 3860649
    [No Abstract]   [Full Text] [Related]  

  • 14. Patch testing with beryllium alloy samples in guinea pigs.
    Zissu D; Binet S; Cavelier C
    Contact Dermatitis; 1996 Mar; 34(3):196-200. PubMed ID: 8833464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies of sensitization to beryllium, zirconium, and aluminum compounds in the rabbit.
    Kang KY; Bice D; Hoffman E; D'Amato R; Salvaggio J
    J Allergy Clin Immunol; 1977 Jun; 59(6):425-36. PubMed ID: 864101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic beryllium disease.
    Constantinidis K
    Br J Clin Pract; 1978 May; 32(5):127-36,53. PubMed ID: 352383
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin granulomata due to beryllium oxide.
    Williams WJ; Lawrie JH; Davies HJ
    Br J Surg; 1967 Apr; 54(4):292-7. PubMed ID: 6021765
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases.
    CURTIS GH
    AMA Arch Derm Syphilol; 1951 Oct; 64(4):470-82. PubMed ID: 14867858
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hypersensitivity to beryllium compounds.
    Marx JJ; Burrell R
    J Immunol; 1973 Aug; 111(2):590-8. PubMed ID: 4717994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.